Glp-2 formulations comprising phosphate buffer, l-histidine and mannitol or sucrose
CA 2395814 C · Owner: Nps Allelix Corp. · Inventors: Isaacs, Indu J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention is directed to formulations of GLP-2 peptides and analogs thereof exhibiting superior stability following storage and/or exposure to elevated temperatures. The GLP-2 compositions comprise a GLP-2 peptide or an analog thereof, a phosphate buffer, L-histidine and mannitol.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 29, 2000 and granted September 20, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 29, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 29, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.